🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
LLY
$LLY
🔒 US EquitiesEli Lilly and Company
AVG HISTORICAL GAP
+1.94%
MAX GAP RECORD
+13.32%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $LLY
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$LLY
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (BEFORE OPEN (08:00)) |
+3.45%
|
| Aug 05, 2026 Earnings Release 2026-08-05 (UNDETERMINED) |
+0.00%
|
| Apr 30, 2026 Earnings Release 2026-04-30 (AFTER CLOSE) |
+1.54%
|
| Feb 04, 2026 Earnings Release 2026-02-04 (BEFORE OPEN) |
+7.14%
|
| Oct 30, 2025 Earnings Release 2025-10-30 (BEFORE OPEN) |
+2.95%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN) |
-9.47%
|
| May 01, 2025 Earnings Release 2025-05-01 (BEFORE OPEN) |
-6.11%
|
| Feb 06, 2025 Earnings Release 2025-02-06 (BEFORE OPEN) |
+0.45%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.9%
Bullish Gaps (10)
Bearish Gaps (4)
Neutral / Flat (1)
📖 Intelligence Summary
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin,…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗